Cite
Lee JE, van Heeswijk R, Alves K, et al. Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother. 2011;55(10):4569-74doi: 10.1128/AAC.00653-11.
Lee, J. E., van Heeswijk, R., Alves, K., Smith, F., & Garg, V. (2011). Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrobial agents and chemotherapy, 55(10), 4569-74. https://doi.org/10.1128/AAC.00653-11
Lee, Jee Eun, et al. "Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin." Antimicrobial agents and chemotherapy vol. 55,10 (2011): 4569-74. doi: https://doi.org/10.1128/AAC.00653-11
Lee JE, van Heeswijk R, Alves K, Smith F, Garg V. Effect of the hepatitis C virus protease inhibitor telaprevir on the pharmacokinetics of amlodipine and atorvastatin. Antimicrob Agents Chemother. 2011 Oct;55(10):4569-74. doi: 10.1128/AAC.00653-11. Epub 2011 Aug 08. PMID: 21825288; PMCID: PMC3187007.
Copy
Download .nbib